In a normal or low-glucose environment, inhibition of PKM2 expression level or enzymatic activity by RNA interference or pharmacological inhibitors, such as shikonin [88,89], efficiently reduces cell survival and tumor growth. This evidence concerns the gene PKM and neoplasm.